Cargando…
Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development
Endometrial carcinoma is the most prevalent gynecologic cancer in the United States. The tumor suppressor gene Pten (phosphatase and tensin homolog) is commonly mutated in the more common type 1 (endometrioid) subtype. The glucose-regulated protein 94 (GRP94) is emerging as a novel regulator for can...
Autores principales: | Shen, Jieli, Yao, Lijing, Lin, Yvonne G., DeMayo, Francesco J., Lydon, John P., Dubeau, Louis, Lee, Amy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924759/ https://www.ncbi.nlm.nih.gov/pubmed/26910913 http://dx.doi.org/10.18632/oncotarget.7450 |
Ejemplares similares
-
Targeting the Glucose Regulated Protein-78 (GRP78) abrogates Pten-null driven AKT-activation and endometrioid tumorigenesis
por: Lin, Yvonne G., et al.
Publicado: (2015) -
The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action
por: Kim, Tae Hoon, et al.
Publicado: (2010) -
Endometrial osseous metaplasia with secondary infertility
por: White, Justin, et al.
Publicado: (2022) -
Progesterone Signaling in Endometrial Epithelial Organoids
por: Hewitt, Sylvia C., et al.
Publicado: (2022) -
Endometrial Osseous Metaplasia: Case Report with Literature Review
por: Patil, SB, et al.
Publicado: (2013)